Enanta Pharmaceuticals, Inc.

NASDAQ:ENTA

Biotechnology

Healthcare
$8.23 -0.67%

-$0.09 today

Market cap
$239.70M
Beta
0.99
P/E (TTM)
-4.3
EPS (TTM)
-$2.90
52W Low $6.44High $17.15

Volume 0.81M

Average 0.17M

Balance Sheet

Inspect the capital base behind the business.

Assets

$280.73M

FY 2025 · Annual

-25.5% YoY

Liabilities

$216.01M

FY 2025 · Annual

-12.8% YoY

Equity

$64.72M

FY 2025 · Annual

-49.8% YoY

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents57.21M43.99M85.39M37.23M32.3M
Short-term Investments186.8M205.24M284.52M210.95M156.57M
Net Receivables60.83M49.04M39.62M38.65M6.88M
Inventory00000
Other Current Assets0013.26M608K8.59M
Total Current Assets319.02M311.71M422.79M299.85M204.34M
Property, Plant & Equipment (Net)10.65M29.75M34.71M73.35M72.94M
Goodwill00000
Intangible Assets00000
Long-term Investments109.02M33.25M3.97M3.36M3.36M
Tax Assets2.07M5.18M000
Other Non-current Assets92K696K803K94K92K
Total Non-current Assets121.84M68.88M39.48M76.8M76.4M
Total Assets440.86M380.59M462.28M376.65M280.73M
Account Payables9.54M6M4.1M8M1.95M
Short-term Debt00034.46M30.71M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities16.34M14.5M35.08M00
Total Current Liabilities36.17M29.83M62.79M57.54M48.56M
Long-term Debt1.51M1.42M0136.13M112.44M
Deferred Tax Liabilities2.07M5.18M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities558K454K161.52M231K260K
Total Non-current Liabilities5.26M29.43M182.75M190.3M167.46M
Total Liabilities41.43M59.26M245.54M247.84M216.02M
Common Stock202K208K211K212K214K
Retained Earnings48.58M(73.18M)(207M)(323.04M)(404.93M)
Accumulated OCI(382K)(3.72M)(1.17M)302K(339K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity399.43M321.33M216.74M128.81M64.72M
Total Debt6.84M26.69M26.51M226.06M201.06M
Net Debt(50.37M)(17.31M)(58.88M)188.83M168.76M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$34.9M
Short-term Investments$128.8M
Receivables$7.8M
Other Current$6.8M
Total Current Assets$178.4M
PP&E (Net)$69.5M
Long-term Investments$66.6M
Other Non-current$144.0K
Total Non-current Assets$136.3M
Total Assets$314.7M

Analysis

Selected assets total $314.7M for Latest. The largest visible component is Short-term Investments at $128.8M, about 40.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 29, 2026
8-KCurrent reportOct 28, 2026
SC 13GSC 13G filingOct 27, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does ENTA have?

Enanta Pharmaceuticals, Inc. (ENTA) reported $32.30M in cash and equivalents in fiscal 2025.

How much debt does ENTA carry?

Enanta Pharmaceuticals, Inc. (ENTA) reported $201.06M of total debt, with net debt of $168.76M.